Motorola shedding biochip biz
Motorola Inc. has put its life sciences business up for sale in a move that is dashing CEO Christopher Galvin’s dream of making biochips the company’s next big success.
Drug makers need a cure for the manufacturing crunch
Over the next several years, growth in demand for biotech production is estimated to outstrip the growth in supply.
Celera Shifts Marketing of Database
The main job of marketing and distributing the database will be shifted to Celera’s sister company, the Applied Biosystems Group, which makes equipment used to study genes and proteins
Was the U.S. government cheated on DNA decoder?
The scribblings of Henry Huang helped start the great race to map the human genome, and they may help settle allegations that the U.S. government got robbed on the way to the finish.
Cultivating Prosperous Partnerships
Like dedicated gardeners — who know that it’s not enough to merely plant seeds and bulbs to create a flourishing landscape — pharmaceutical companies have come to realize that tending to their partnering relationships is critical to achieving the best results.